Literature DB >> 9211476

The relationship of nausea and dyspnea to pain in seriously ill patients.

N A Desbiens1, N Mueller-Rizner, A F Connors, N S Wenger.   

Abstract

OBJECTIVE: To describe the hospital symptom experience of seriously ill patients with common illnesses. To assess the independent association of nausea and dyspnea to level of pain.
DESIGN: Cross-sectional study.
SETTING: Five tertiary care academic centers in the US. PARTICIPANTS: 1556 patients admitted between June 1989 and June 1991 in SUPPORT (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) who answered questions concerning frequency and severity of pain, nausea and dyspnea, and the depression and anxiety subscales of the Profile of Mood States.
METHODS: Seriously ill patients were interviewed a median of 8 days after hospitalization concerning the frequency and severity of their pain, nausea and dyspnea. Frequencies of symptoms and symptom combinations were tabulated. Ordinal logistic regression was used to test the independent association of level of pain with nausea and dyspnea. The analysis was adjusted for 22 additional demographic, psychological, chronic and acute illness measures.
RESULTS: At least some level of anxious mood was reported by 85.2% of patients, depressed mood by 72.3% of patients, pain by 51.2% of patients, dyspnea by 48.6% of patients and nausea by 23.9% of patients. At least some degree of one of the five symptoms was reported by 94.2% of patients. Multivariable analysis controlling for demographic, psychological, and chronic and acute illness variables revealed that nausea and dyspnea were independently related to level of pain. Compared to patients without these symptoms, patients who reported mild (level 2), moderate (level 3), more severe (level 4) and very severe (level 5) nausea had odds ratios (OR) for higher levels of pain of 1.62 (1.24, 2.12) (95% confidence interval), 2.36 (1.39, 4.00), 2.57 (1.29, 5.12) and 2.22 (1.08, 4.53), respectively. Compared to patients without these symptoms, patients who reported mild (level 2), moderate (level 3), more severe (level 4) and very severe (level 5) dyspnea had odds ratios (OR) for higher levels of pain of 1.49 (1.17, 1.90), 1.92 (1.21, 3.04), 2.73 (1.83, 4.07) and 1.95 (1.39, 2.73), respectively.
CONCLUSIONS: Seriously ill patients have a high symptom burden. Patients who have nausea and dyspnea experience more pain than patients without these symptoms, even after adjustment for depression, anxiety, disease type, disease severity and demographic and psychological measures. The causal association between these symptoms and pain remains to be determined. Though pain may cause dyspnea and nausea, the intriguing possibility remains that, in addition to relieving suffering, treating dyspnea and nausea may relieve pain.

Entities:  

Mesh:

Year:  1997        PMID: 9211476     DOI: 10.1016/s0304-3959(97)03353-8

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  14 in total

1.  Routine dyspnea assessment on unit admission.

Authors:  Kathy Baker; Jennifer Barsamian; Danielle Leone; Barbara C Donovan; Donna Williams; Kerry Carnevale; Robert Lansing; Robert Banzett
Journal:  Am J Nurs       Date:  2013-11       Impact factor: 2.220

2.  An update in symptom clusters using the Edmonton Symptom Assessment System in a palliative radiotherapy clinic.

Authors:  Vithusha Ganesh; Liying Zhang; Stephanie Chan; Bo Angela Wan; Leah Drost; May Tsao; Cyril Danjoux; Elizabeth Barnes; Rachel McDonald; Leigha Rowbottom; Pearl Zaki; Ronald Chow; Matthew K Hwang; Carlo DeAngelis; Nicholas Lao; Edward Chow
Journal:  Support Care Cancer       Date:  2017-05-23       Impact factor: 3.603

3.  The Trajectory of Dyspnea in Hospitalized Patients.

Authors:  Ernest DiNino; Mihaela S Stefan; Aruna Priya; Benjamin Martin; Penelope S Pekow; Peter K Lindenauer
Journal:  J Pain Symptom Manage       Date:  2015-11-24       Impact factor: 3.612

4.  The relationship of cancer symptom clusters to depressive affect in the initial phase of palliative radiation.

Authors:  Richard Benoit Francoeur
Journal:  J Pain Symptom Manage       Date:  2005-02       Impact factor: 3.612

5.  Controlled Delivery of 80 mg Aerosol Furosemide Does Not Achieve Consistent Dyspnea Relief in Patients.

Authors:  Robert W Hallowell; Richard Schwartzstein; Carl R O'Donnell; Andrew Sheridan; Robert B Banzett
Journal:  Lung       Date:  2019-11-15       Impact factor: 2.584

6.  An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.

Authors:  Mark B Parshall; Richard M Schwartzstein; Lewis Adams; Robert B Banzett; Harold L Manning; Jean Bourbeau; Peter M Calverley; Audrey G Gift; Andrew Harver; Suzanne C Lareau; Donald A Mahler; Paula M Meek; Denis E O'Donnell
Journal:  Am J Respir Crit Care Med       Date:  2012-02-15       Impact factor: 21.405

7.  Symptom burden and supportive care in patients with acute leukemia.

Authors:  Camilla Zimmermann; Dora Yuen; Ashley Mischitelle; Mark D Minden; Joseph M Brandwein; Aaron Schimmer; Lucia Gagliese; Christopher Lo; Anne Rydall; Gary Rodin
Journal:  Leuk Res       Date:  2013-03-11       Impact factor: 3.156

Review 8.  The multiple dimensions of dyspnea: review and hypotheses.

Authors:  Robert W Lansing; Richard H Gracely; Robert B Banzett
Journal:  Respir Physiol Neurobiol       Date:  2008-07-25       Impact factor: 1.931

Review 9.  Physiologic changes and clinical correlates of advanced dyspnea.

Authors:  Sean A Gilman; Robert B Banzett
Journal:  Curr Opin Support Palliat Care       Date:  2009-06       Impact factor: 2.302

10.  Prevalence of Dyspnea Among Hospitalized Patients at the Time of Admission.

Authors:  Jennifer P Stevens; Tenzin Dechen; Richard Schwartzstein; Carl O'Donnell; Kathy Baker; Michael D Howell; Robert B Banzett
Journal:  J Pain Symptom Manage       Date:  2018-02-22       Impact factor: 3.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.